JPMorgan increases its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.02 per share.
On September 11, JPMorgan increased its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.0248 per share, for a total amount of approximately HK$535 million.
The latest information from the Hong Kong Stock Exchange shows that on September 11, JPMorgan increased its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.0248 per share, for a total amount of approximately HK$535 million. After the increase, its latest shareholding is approximately 165 million shares, with its latest shareholding percentage at 7.48%.
Related Articles
ZHONG JIA GX (00899) completes the placement of a total of 29,677,300 placing shares.
Valiant Co.,Ltd(002643.SZ)'s controlling subsidiary Jiumu Chemical's Beijing Stock Exchange listing application passed the review by the Listing Committee.
SANBASE CORP (08501) intends to sell a 60% equity interest in Core Group Holding Limited for HK$27 million.
ZHONG JIA GX (00899) completes the placement of a total of 29,677,300 placing shares.
Valiant Co.,Ltd(002643.SZ)'s controlling subsidiary Jiumu Chemical's Beijing Stock Exchange listing application passed the review by the Listing Committee.
SANBASE CORP (08501) intends to sell a 60% equity interest in Core Group Holding Limited for HK$27 million.
RECOMMEND
